Literature DB >> 20878713

Structural, functional, and bioinformatics studies reveal a new snake venom homologue phospholipase A₂ class.

Juliana I dos Santos1, Mariana Cintra-Francischinelli, Rafael J Borges, Carlos A H Fernandes, Paola Pizzo, Adélia C O Cintra, Antonio S K Braz, Andreimar M Soares, Marcos R M Fontes.   

Abstract

Phospholipases A₂ (PLA₂s) are enzymes responsible for membrane disruption through Ca(2+) -dependent hydrolysis of phospholipids. Lys49-PLA₂s are well-characterized homologue PLA₂s that do not show catalytic activity but can exert a pronounced local myotoxic effect. These homologue PLA₂s were first believed to present residual catalytic activity but experiments with a recombinant toxin show they are incapable of catalysis. Herein, we present a new homologue Asp49-PLA₂ (BthTX-II) that is also able to exert muscle damage. This toxin was isolated in 1992 and characterized as presenting very low catalytic activity. Interestingly, this myotoxic homologue Asp49-PLA₂ conserves all the residues responsible for Ca(2+) coordination and of the catalytic network, features thought to be fundamental for PLA₂ enzymatic activity. Previous crystallographic studies of apo BthTX-II suggested this toxin could be catalytically inactive since a distortion in the calcium binding loop was observed. In this article, we show BthTX-II is not catalytic based on an in vitro cell viability assay and time-lapse experiments on C2C12 myotube cell cultures, X-ray crystallography and phylogenetic studies. Cell culture experiments show that BthTX-II is devoid of catalytic activity, as already observed for Lys49-PLA₂s. Crystallographic studies of the complex BthTX-II/Ca(2+) show that the distortion of the calcium binding loop is still present and impairs ion coordination even though Ca(2+) are found interacting with other regions of the protein. Phylogenetic studies demonstrate that BthTX-II is more phylogenetically related to Lys49-PLA₂s than to other Asp49-PLA₂s, thus allowing Crotalinae subfamily PLA₂s to be classified into two main branches: a catalytic and a myotoxic one.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878713     DOI: 10.1002/prot.22858

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  12 in total

1.  Purification, crystallization and preliminary X-ray diffraction analysis of an acidic phospholipase A2 with vasoconstrictor activity from Agkistrodon halys pallas venom.

Authors:  Zhisong Zou; Fuxing Zeng; Lu Zhang; Liwen Niu; Maikun Teng; Xu Li
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-10-30

2.  Crystallization and preliminary X-ray diffraction analysis of three myotoxic phospholipases A2 from Bothrops brazili venom.

Authors:  Carlos A H Fernandes; Elaine C G Gartuzo; Ivan Pagotto; Edson J Comparetti; Salomón Huancahuire-Vega; Luis Alberto Ponce-Soto; Tássia R Costa; Sergio Marangoni; Andreimar M Soares; Marcos R M Fontes
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-07-31

3.  Structural and functional studies of a bothropic myotoxin complexed to rosmarinic acid: new insights into Lys49-PLA₂ inhibition.

Authors:  Juliana I Dos Santos; Fábio F Cardoso; Andreimar M Soares; Maeli Dal Pai Silva; Márcia Gallacci; Marcos R M Fontes
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

4.  Ac2-26 Mimetic Peptide of Annexin A1 Inhibits Local and Systemic Inflammatory Processes Induced by Bothrops moojeni Venom and the Lys-49 Phospholipase A2 in a Rat Model.

Authors:  Bruna Stuqui; Marina de Paula-Silva; Carla Patrícia Carlos; Anwar Ullah; Raghuvir Krishnaswamy Arni; Cristiane Damas Gil; Sonia Maria Oliani
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

5.  Synergism between basic Asp49 and Lys49 phospholipase A2 myotoxins of viperid snake venom in vitro and in vivo.

Authors:  Diana Mora-Obando; Julián Fernández; Cesare Montecucco; José María Gutiérrez; Bruno Lomonte
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

6.  Photobiomodulation Protects and Promotes Differentiation of C2C12 Myoblast Cells Exposed to Snake Venom.

Authors:  Luciana Miato Gonçalves Silva; Camila Aparecida Alves da Silva; Aline da Silva; Rodolfo Paula Vieira; Raquel Agnelli Mesquita-Ferrari; José Carlos Cogo; Stella Regina Zamuner
Journal:  PLoS One       Date:  2016-04-08       Impact factor: 3.240

7.  Structural and phylogenetic studies with MjTX-I reveal a multi-oligomeric toxin--a novel feature in Lys49-PLA2s protein class.

Authors:  Guilherme H M Salvador; Carlos A H Fernandes; Angelo J Magro; Daniela P Marchi-Salvador; Walter L G Cavalcante; Roberto M Fernandez; Márcia Gallacci; Andreimar M Soares; Cristiano L P Oliveira; Marcos R M Fontes
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

Review 8.  Antitumoral potential of Tunisian snake venoms secreted phospholipases A2.

Authors:  Raoudha Zouari-Kessentini; Najet Srairi-Abid; Amine Bazaa; Mohamed El Ayeb; Jose Luis; Naziha Marrakchi
Journal:  Biomed Res Int       Date:  2013-01-31       Impact factor: 3.411

9.  A novel phospholipase A2 (D49) from the venom of the Crotalus oreganus abyssus (North American Grand canyon rattlesnake).

Authors:  W Martins; P A Baldasso; K M Honório; V G Maltarollo; R I M A Ribeiro; B M A Carvalho; A M Soares; L A Calderon; R G Stábeli; M A O Caballol; G Acosta; E Oliveira; S Marangoni; F Albericio; S L Da Silva
Journal:  Biomed Res Int       Date:  2014-02-24       Impact factor: 3.411

10.  Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and Isolated Phospholipases A2 by Specific Camelid Single-Domain Antibody Fragments.

Authors:  Nidiane D R Prado; Soraya S Pereira; Michele P da Silva; Michelle S S Morais; Anderson M Kayano; Leandro S Moreira-Dill; Marcos B Luiz; Fernando B Zanchi; André L Fuly; Maribel E F Huacca; Cleberson F Fernandes; Leonardo A Calderon; Juliana P Zuliani; Luiz H Pereira da Silva; Andreimar M Soares; Rodrigo G Stabeli; Carla F C Fernandes
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.